Selskabets formål er udvikling og kommercialisering af lægemidler og hermed forbundet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | -842 t. | 1.4 mio. | 1.1 mio. | 1.1 mio. | 5 | |
CVR: 39691175
Company placed under bankruptcy proceedings
EY Godkendt Revisionspartnerselskab resigned as auditor
Preben Jakobsen left as liquidator
Company exited liquidation
Companies in the same industry and area
CVR 45506983
CVR 44695065
CVR 46314964
CVR 40172076
CVR 44828596
Compared to 999 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
companydata.dk